Results 201 to 210 of about 13,385,789 (308)
Alignment of countries in the Americas with the latest WHO guidelines for hepatitis B virus (HBV) infection: a review. [PDF]
Perazzo H +4 more
europepmc +1 more source
ABSTRACT Introduction Viral hepatitis remains a major global public health challenge, with heterogeneous epidemiological patterns across geographic and socioeconomic contexts. In the Brazilian Amazon, evidence remains limited, particularly regarding long‐term trends.
Jamilla Karla Corrêa Reis +6 more
wiley +1 more source
Seroprevalence of Human Immunodeficiency Virus (HIV), Hepatitis B Virus (HBV), and Hepatitis C Virus (HCV) Among Blood Donors in Borgou, Benin in 2023: A Cross-Sectional Study. [PDF]
Djaliri KD +4 more
europepmc +1 more source
ABSTRACT Multimorbidity is a growing public health challenge in low‐ and middle‐income countries (LMICs), where resource‐limited and fragmented health systems impede coordinated disease detection and management. Integrated screening offers a promising strategy to improve early detection of communicable and non‐communicable diseases.
Evans Duah +7 more
wiley +1 more source
Prevalence and Risk Factors of Hepatocellular Carcinoma in Patients Co-infected With Hepatitis B Virus (HBV) and Hepatitis C Virus (HCV): A Cross-Sectional Retrospective Study. [PDF]
Iqbal S +10 more
europepmc +1 more source
Abstract Background Blood donor screening occasionally identifies individuals with high HBV surface antigen (HBsAg) levels despite undetectable or extremely low HBV DNA. Molecular basis and transfusion risk of this discordant profile remain unclear. Study Design and Methods Seventy‐five blood donors with HBsAg >100 IU/mL and undetectable or very low ...
Maelenn Païline Delcourt +8 more
wiley +1 more source
To Switch or not to Switch to Long-acting Injectable Cabotegravir/Rilpivirine in PWH With Past Hepatitis B Virus (HBV) Coinfection: Which HBV Markers to Manage Risk of HBV Reactivation? [PDF]
Ollier L +7 more
europepmc +1 more source
Abstract Background Blood donor deferral for malaria risk relies exclusively on responses to self‐reported questionnaires. This study evaluated the economic impact of introducing Plasmodium nucleic acid testing (NAT) as a universal screening strategy in the United States.
Cristina Coll‐Ortega +3 more
wiley +1 more source
Abstract Objective Data on the long‐term stability and reproducibility of nucleic acid amplification testing (NAT) results in frozen stored positive samples (≤−20°C) remain limited. This study evaluated the long‐term performance of frozen virus‐positive samples in quantitative PCR assays and aimed to provide evidence for their analytical reliability in
Benjamin Marx +6 more
wiley +1 more source

